ILU:ASXIluka Resources Limited Analysis
Data as of 2026-08-24 - not real-time
A$7.35
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Iluka Resources Limited trades at AUD 7.35, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has gained 13.6% over the past 30 days. Momentum indicators put RSI at 61.5 (approaching overbought) with MACD reading bullish. Watch AUD 5.75 as support and AUD 7.49 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 9.2% above the current price. Revenue is contracting at 21.1% on a -45.2% profit margin. The 0.86% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 45.1%, a beta of 1.04 and a maximum drawdown of 46.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 9.2% above the current price. Revenue is contracting at 21.1% on a -45.2% profit margin. The 0.86% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 45.1%, a beta of 1.04 and a maximum drawdown of 46.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
Iluka Resources ASX:ILU reports lower mineral sands revenue in H1 2026 but advances Eneabba rare earths refinery and...Iluka Resources Q1 2026 saw lower revenue and production, but major minerals and rare earths projects continue to...Shareholders in Iluka Resources Limited ASX:ILU may be thrilled to learn that the analysts have just delivered a.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 6.73
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 6.73
- Analyst targets imply +9.2% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -45.2%
- Analyst targets imply +9.2% versus the current price
- Negative return on equity of -18.0%
Key Metrics & Analysis
Financial Health
Revenue Growth-21.10%
Profit Margin-45.25%
P/E Ratio-24.8
ROE-18.00%
ROA-2.86%
Debt/Equity62.99
P/B Ratio1.6
Op. Cash FlowA$190.1M
Free Cash FlowA$-411312512
Technical Analysis
TrendBullish
RSI61.5
SupportA$5.75
ResistanceA$7.49
MA 20A$6.82
MA 50A$6.82
MA 200A$6.73
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair ValueA$1.09
Target PriceA$8.03
Upside/Downside9.18%
GradeFair
TypeBlend
Dividend Yield0.86%
Risk Assessment
Beta1.04
Volatility45.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.